Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by gojotv!on Jun 16, 2021 1:28pm
132 Views
Post# 33395916

For those who lost the plot...

For those who lost the plot...Despite Q4 2020 being our most profitable ever...

"The first quarter of 2021 was transformative for StageZero," said James Howard-Tripp, Chairman and CEO of StageZero. "We are a vastly different company, with significantly greater growth opportunities from when we closed out 2020. We are a robust company with the ability to capitalize on strong healthcare trends and drive long-term growth. Our Q1 achievements, particularly our pending acquisition of Health Clinics Limited, are foundational to our ambition to reduce the incidence of late-stage cancer by 50% over the next decade through early interventions. They are also core to our future as a company and the value we strive to generate for patients and our shareholders."

So, yeah, I'm on board for ALL of that!
<< Previous
Bullboard Posts
Next >>